Mouse models of nonalcoholic steatohepatitis in preclinical drug development.
Sign Up to like & getrecommendations! Published in 2017 at "Drug discovery today"
DOI: 10.1016/j.drudis.2017.06.007
Abstract: Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease in the Western world. NAFLD is a complex spectrum of liver diseases ranging from benign hepatic steatosis to its more… read more here.
Keywords: mouse models; nonalcoholic steatohepatitis; preclinical drug; steatohepatitis preclinical ... See more keywords